A medication to treat Type 2 diabetes has significantly reduced blood sugar and body weight in participants of a late-phase clinical trial. Eli Lilly’s Tirzepatide is in
There’s plenty of broad coverage in this issue, with a lengthy look at the food sector with a round up of news from suppliers, proprietors
On the cover, there’s an invite for you to take a look at the online offerings happening on World Diabetes Day – 14 November (well,
Air Liquide Healthcare, the company that brought the Tandem t:slim X2 insulin pump to the UK, reports that the roll out of its Control-IQ closed-loop
Most of us are happy with our blood test meters. Every now and then, we may need to upgrade. Nick Cahm looks at 10 things
Covid is catalyzing the adoption of contactless biometrics, according to website CB Insights: “Covid-19 is unsurprisingly catalyzing the adoption of contactless biometrics. Big tech companies and
Drugs developed to treat Alzheimer’s disease could be repurposed to prevent damage caused to blood vessels in people with Type 2 diabetes after researchers discovered
PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, have announced a strategic partnership with Senseonics Holdings, a medical technology company focused on
Companion Medical will help the company expand its diabetes management offerings, as reported by Catherine Roberts and Joe Carlson for the Star Tribune newspaper in
Diabetes Research and Wellness Foundation (DRWF) is the latest organisation to add podcasts to its range of communications. Why Podcasts? Podcast audiences are growing, Apple Podcasts
